Mapping large numbers of results may take a few moments.
|Company AskBio||Activity: Research and Development||Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders.||Location Research Triangle Park|
|Company BioCytics Inc.||Activity: Research and Development||Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is incubated within the Carolina BioOncology Institute.||Location Huntersville|
|Company bluebird bio Inc.||Activity: Production and Manufacturing||Company Description bluebird bio develops gene therapies and cancer immunotherapies for the treatment of genetic diseases and cancer. At its Durham site, bluebird produces lentiviral vectors for the company's gene and cell therapies.||Location Durham|
|Company Life Edit Therapeutics||Activity: Research and Development||Company Description Life Edit Therapeutics leverages its bioinformatic pipeline to identify novel genome editing systems from a database of microbial genomes. These systems are then developed for use as human therapeutics, both in-house and through external partnerships.||Location Morrisville|
|Company Locus Biosciences Inc.||Activity: Research and Development||Company Description Locus Biosciences is developing CRISPR-engineered bacteriophage (“crPhage”) products that kill target bacteria by irreversibly destroying their DNA while leaving the many species of beneficial bacteria in the body unharmed.||Location Morrisville|
|Company Twin City Bio LLC||Activity: Production and Manufacturing||Company Description Twin City Bio manufactures cell therapy products that use a patient's own cells to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organs.||Location Winston-Salem|